Hua-Jay Jeffery Cherng MD (He/Him)

Oncology•New York, NY

Hematologic Oncology

Assistant Professor of Medicine

Request appointment

161 Fort Washington AvenueFloor GNew York, NY 10032
Book by Phone+1(435) 295-4071

Overview of Dr. Cherng

Hua-Jay Cherng, MD, is an oncologist specializing in hematologic oncology, located in New York, NY. He completed his medical education at Case Western Reserve University School of Medicine and underwent extensive postgraduate training in internal medicine and hematology/medical oncology at both the University of Pennsylvania Health System and the University of Texas Health Science Center at Houston/M D Anderson Cancer Center. He served as a Clinical Fellow at the latter institution and as a Resident Physician at the University of Pennsylvania. He is experienced in internal medicine and medical oncology, with several publications in peer-reviewed journals on lymphoma and related topics.

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
University of Pennsylvania Health System/Pennsylvania HospitalResidency, Internal Medicine, 2016 - 2019
University of Pennsylvania Health SystemInternship, Internal Medicine, 2016 - 2019
Case Western Reserve University School of MedicineClass of 2016

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2022 - 2027
TX State Medical License 2019 - 2024
PA State Medical License 2018 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Nivolumab with doxorubicin, vinblastine, and dacarbazine in older adults with classic Hodgkin lymphoma: do S1826 results hold up in the real world?
Pallawi Torka, Allison M Bock, Peirong Hao, Yizhe Xu, Swetha K Thiruvengadam
Haematologica. 2026-10-08
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.
Cassandra Duarte, Grace N Bosma, Diana Abbott, Gaston Jean-Louis, Maciej Kabat
European Journal of Haematology. 2026-09-18
Post-treatment circulating tumor DNA in large B-cell lymphoma with an immunoglobulin-based assay: real-world outcomes.
Patrick Gould, Devyn Coskey, Xin Ma, Shikun Wang, Sonia Godbole
Haematologica. 2026-08-13

Press Mentions

Foresight Diagnostics Announces Launch of SHORTEN-ctDNA Trial to Evaluate Personalized Treatment Duration in DLBCL Lymphoma PatientsDecember 5th, 2024